QC
MJN

QCM Cayman’s Mead Johnson Nutrition Company MJN Stock Holding History

QCM Cayman’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-3,301
Closed -$274K – 382
2014
Q1 		$274K Buy
+3,301
New +$268K 0.06% 194

Other funds holding MJN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

QCM Cayman's MJN Position: Q2 2014 in Review

QCM Cayman sold out of Mead Johnson Nutrition Company (MJN) in Q2 2014, closing a stake of 3,301 shares — an estimated $274K sold.

QCM Cayman first reported a position in MJN in Q1 2014 and held it in 1 quarter. The position peaked at $274K in Q1 2014. 514 funds tracked by Wall St. Rank hold MJN as of Q2 2014.

  • QCM Cayman reported no remaining Mead Johnson Nutrition Company position as of Q2 2014 after selling out during the quarter.
  • QCM Cayman sold 3,301 Mead Johnson Nutrition Company shares in Q2 2014, an estimated $274K.
  • QCM Cayman first reported a position in Mead Johnson Nutrition Company in Q1 2014 and held it in 1 quarter.
  • QCM Cayman's Mead Johnson Nutrition Company position peaked at $274K in Q1 2014.
  • 514 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2014.

Based on QCM Cayman's 13F filing for Q2 2014, filed 14 Aug 2014.